M. Hassan, “Beyond weight loss: the long-term effects of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatohepatitis and fibrosis regression”, Int J Res Med Sci, vol. 14, no. 11, pp. 5321–5331, Oct. 2026.